Skip to search formSkip to main contentSkip to account menu

satranidazole

Known as: 1-methanesulfonyl-3-(1-methyl-5-nitroimidazol-2-yl)-2-imidazolidinone, 2-Imidazolidinone, 1-(1-methyl-5-nitro-1H-imidazol-2-yl)-3-(methylsulfonyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The solubility and dissolution properties of drugs play an important role in the process of formulation development. Among all… 
2013
2013
Objective: The goal in using a local nonsurgical controlled intrapocket device for the delivery of an antimicrobial agent is the… 
2013
2013
The delivery of drugs to the colon through oral route is valuable in treating diseases of the colon with the expectation to… 
2011
2011
In the present work, an attempt has been made to enhance solubility and dissolution of poorly water soluble drug, satranidazole… 
2011
2011
The Extended Hildebrand Solubility Parameter Approach (EHSA) is used to estimate the solubility of satranidazole in binary… 
2009
2009
A simple, selective, rapid and precise reverse phase HPLC method has been developed for the simultaneous estimation of Ofloxacin… 
2009
2009
A new sensitive, simple, rapid and precise method for simultaneous estimation of Ofloxacin and Satranidazole in bulk and combined… 
2008
2008
Three simple, precise and economical UV methods have been developed for the estimation of Satranidazole in tablet dosage form… 
2008
2008
A simple, selective, rapid, precise and accurate reverse phase high performance liquid chromatographic method has been developed… 
2003
2003
Two simple, accurate and precise spectrophotometric methods have been developed for simultaneous determination of satranidazole…